Responses to Information on Treatments for Depression

NCT ID: NCT04639765

Last Updated: 2021-09-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

300 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-10-28

Study Completion Date

2020-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine the impact of different messages about depression treatments.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Participants recruited through Amazon Mechanical Turk (MTurk) will complete a screening questionnaire and provided the opportunity to consent to participate. Upon entry to the study, eligible participants will complete several questionnaires pre- and post-randomization. Randomization will be to view either a video detailing a type of depression treatment (cognitive behavioral therapy, antidepressant medication, or the combination of both treatments) with and without an emphasis on personalization. A no video condition is also included.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Depressive Symptoms

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

No video

This condition involves no video presentation.

Group Type NO_INTERVENTION

No interventions assigned to this group

CBT without Personalization

Video provides information about cognitive behavioral therapy.

Group Type EXPERIMENTAL

CBT without Personalization

Intervention Type OTHER

Intervention involves a video describing CBT without a message about personalization.

CBT with Personalization

Video provides information about cognitive behavioral therapy and describes how treatment can be personalized.

Group Type EXPERIMENTAL

CBT with Personalization

Intervention Type OTHER

Intervention involves a video describing CBT with a message about personalization.

ADM without Personalization

Video provides information about antidepressant medications.

Group Type EXPERIMENTAL

ADM without Personalization

Intervention Type OTHER

Intervention involves a video describing antidepressant medication without a message about personalization.

ADM with Personalization

Video provides information about antidepressant medications and describes how treatment can be personalized.

Group Type EXPERIMENTAL

ADM with Personalization

Intervention Type OTHER

Intervention involves a video describing antidepressant medication with a message about personalization.

Combined Treatment without Personalization

Video provides information on the combined treatment of cognitive behavioral therapy with antidepressant medications.

Group Type EXPERIMENTAL

Combined Treatment without Personalization

Intervention Type OTHER

Intervention involves a video describing the combination of cognitive behavior therapy and antidepressant medication without a message about personalization.

Combined Treatment with Personalization

Video provides information on the combined treatment of cognitive behavioral therapy with antidepressant medications and describes how treatment can be personalized.

Group Type EXPERIMENTAL

Combined Treatment with Personalization

Intervention Type OTHER

Intervention involves a video describing the combination of cognitive behavior therapy and antidepressant medication with a message about personalization.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CBT without Personalization

Intervention involves a video describing CBT without a message about personalization.

Intervention Type OTHER

CBT with Personalization

Intervention involves a video describing CBT with a message about personalization.

Intervention Type OTHER

ADM without Personalization

Intervention involves a video describing antidepressant medication without a message about personalization.

Intervention Type OTHER

ADM with Personalization

Intervention involves a video describing antidepressant medication with a message about personalization.

Intervention Type OTHER

Combined Treatment without Personalization

Intervention involves a video describing the combination of cognitive behavior therapy and antidepressant medication without a message about personalization.

Intervention Type OTHER

Combined Treatment with Personalization

Intervention involves a video describing the combination of cognitive behavior therapy and antidepressant medication with a message about personalization.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* PHQ-9 Score indicating a history of elevated depression symptoms
* A high MTurk completion rate
* Must pass all attention checks inserted into the questionnaires
* No history of treatment for depression

Exclusion Criteria

* none
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ohio State University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Daniel R. Strunk

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Daniel Strunk, PhD

Role: PRINCIPAL_INVESTIGATOR

Professor

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Psychology Building 1835 Neil Avenue

Columbus, Ohio, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2020B0259

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Preventing Perinatal Depression
NCT06525922 COMPLETED NA
Treatment of Post-TBI Depression
NCT00211835 COMPLETED NA